Barchart on Facebook
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Biotechnology Index NYSE ETF (FBT)

Biotechnology Index NYSE ETF (FBT)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fund Basics

See More
  • Fund Family First Trust Portfolios
  • Assets Under Management 1,928,762,400
  • Market Capitalization, $K 1,928,762
  • Shares Outstanding, K 12,250
  • 60-Month Beta 1.26
Trade FBT with:
  • Price/Earnings ttm 24.10
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend 0.020 on 09/23/15
  • Management Fee 0.55%
  • Sectors:

    ETFs - Biotech

Price Performance

See More
Period Period Low Period High Performance
1-Month
153.88 +0.94%
on 10/26/20
165.41 -6.09%
on 10/13/20
+0.18 (+0.12%)
since 09/25/20
3-Month
149.50 +3.90%
on 09/11/20
173.49 -10.47%
on 07/27/20
-13.88 (-8.20%)
since 07/24/20
52-Week
108.08 +43.72%
on 03/18/20
180.64 -14.01%
on 07/20/20
+26.24 (+20.33%)
since 10/25/19

Most Recent Stories

More News
Biotech ETFs in Focus as the COVID-19 Vaccine Race Intensifies

Johnson & Johnson's entry into the late-stage trials has increased optimism in the coronavirus vaccine development.

IBB : 135.11 (-1.01%)
XBI : 116.05 (-1.34%)
BBH : 156.59 (-1.46%)
FBT : 155.33 (-1.45%)
ARKG : 69.11 (-1.43%)
How Will Biotech ETFs React to Vaccine Makers' Safety Pledge?

Nine vaccine developers have jointly pledged to observe high ethical standards in conducting clinical studies and manufacturing of vaccines.

IBB : 135.11 (-1.01%)
XBI : 116.05 (-1.34%)
BBH : 156.59 (-1.46%)
FBT : 155.33 (-1.45%)
ARKG : 69.11 (-1.43%)
Biotech ETFs to Shine Bright on Coronavirus Vaccine Progress

AstraZeneca's initiation of a phase III study has heated up competition to bring a coronavirus vaccine to the markets.

AZN : 53.07 (+2.06%)
IBB : 135.11 (-1.01%)
XBI : 116.05 (-1.34%)
BBH : 156.59 (-1.46%)
FBT : 155.33 (-1.45%)
ARKG : 69.11 (-1.43%)
Red Hot ETF Areas Amid the Coronavirus Crisis

Let's check out some ETF areas that will remain solid investment picks even as the coronavirus cases show a sharp spike.

IBB : 135.11 (-1.01%)
XBI : 116.05 (-1.34%)
PNQI : 214.53 (-1.50%)
FBT : 155.33 (-1.45%)
ARKW : 116.22 (-1.96%)
FDN : 195.94 (-1.93%)
ESGU : 77.39 (-1.83%)
ESGV : 62.96 (-1.82%)
OGIG : 46.50 (-1.51%)
USSG : 30.82 (-2.16%)
How Are Biotech ETFs Reacting to Coronavirus Treatment News?

Here we take a look at how the latest updates on drugs, antibody therapies and vaccines targeted at winning the coronavirus battle can affect biotech ETFs.

GILD : 59.96 (-1.37%)
LLY : 141.70 (-0.48%)
IBB : 135.11 (-1.01%)
XBI : 116.05 (-1.34%)
BBH : 156.59 (-1.46%)
FBT : 155.33 (-1.45%)
ARKG : 69.11 (-1.43%)
Biotech ETFs Soaring on COVID-19 Vaccine Progress

Novavax's latest progress in the Covid-19 vaccine development brings optimism to the Wall Street.

JNJ : 143.97 (-0.87%)
AZN : 53.07 (+2.06%)
MRNA : 70.24 (-0.41%)
NVAX : 87.38 (-6.17%)
IBB : 135.11 (-1.01%)
XBI : 116.05 (-1.34%)
BBH : 156.59 (-1.46%)
FBT : 155.33 (-1.45%)
ARKG : 69.11 (-1.43%)
Ride Out the Coronavirus Mayhem With These ETF Areas

We discuss some ETF areas that investors can choose to invest for a smoother sail during the coronavirus pandemic.

AMZN : 3,207.04 (+0.08%)
GILD : 59.96 (-1.37%)
IBB : 135.11 (-1.01%)
BABA : 306.87 (-0.98%)
XBI : 116.05 (-1.34%)
BBH : 156.59 (-1.46%)
FBT : 155.33 (-1.45%)
IBUY : 95.10 (-1.74%)
BOTZ : 28.42 (-2.13%)
SKYY : 79.81 (-2.79%)
CLIX : 87.42 (+0.33%)
ARKG : 69.11 (-1.43%)
ONLN : 66.78 (-0.91%)
Healthcare & Biotech ETFs Digest GILD's Failure News: 5 Winners

Biotech and healthcare ETFs were pretty stable on Apr 23 despite the news that Gilead's Remdesivir failed to improve Covid-19 patients' condition.

GILD : 59.96 (-1.37%)
IBB : 135.11 (-1.01%)
CNCR : 27.37 (-2.11%)
BBH : 156.59 (-1.46%)
FBT : 155.33 (-1.45%)
PTH : 142.06 (-1.26%)
IHF : 212.96 (-1.97%)
IHE : 165.95 (-1.28%)
XPH : 45.57 (-1.77%)
SBIO : 44.39 (-0.38%)
XHS : 81.44 (-1.73%)
PBE : 59.16 (-0.85%)
IDNA : 39.53 (-0.33%)
Ride Out the Coronavirus Mayhem With These ETF Areas

We discuss some ETF areas that investors can choose to invest for a smoother sail during the coronavirus pandemic.

AMZN : 3,207.04 (+0.08%)
GILD : 59.96 (-1.37%)
IBB : 135.11 (-1.01%)
BABA : 306.87 (-0.98%)
XBI : 116.05 (-1.34%)
BBH : 156.59 (-1.46%)
FBT : 155.33 (-1.45%)
IBUY : 95.10 (-1.74%)
BOTZ : 28.42 (-2.13%)
ROBO : 49.49 (-2.52%)
SKYY : 79.81 (-2.79%)
CLIX : 87.42 (+0.33%)
ARKG : 69.11 (-1.43%)
Coronavirus Makes Biotech ETFs Red Hot

The biotech space of the broader healthcare sector is currently the hottest of all segments buoyed by the COVID-19 pandemic.

REGN : 585.74 (+1.02%)
PFE : 37.92 (-0.68%)
GILD : 59.96 (-1.37%)
MRNA : 70.24 (-0.41%)
ABT : 109.00 (+1.12%)
AMGN : 224.89 (-1.00%)
TMO : 482.43 (+0.47%)
IBB : 135.11 (-1.01%)
INO : 10.45 (-4.57%)
BBH : 156.59 (-1.46%)
FBT : 155.33 (-1.45%)
ARKG : 69.11 (-1.43%)
IEIH : 29.89 (-0.96%)
BNTX : 82.93 (-6.49%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 16% Sell with a Weakening short term outlook on maintaining the current direction.

The market is approaching oversold territory. Be watchful of a trend reversal.

See More Share

Fund Summary

The First Trust NYSE Arca Biotechnology Index Fund is and exchange-traded index fund. The investment objective of the fund is to replicate as closely as possible, before fees and expenses, the price and yield of the NYSE Arca Biotechnology Index. The NYSE Arca Biotechnology Index is an equal dollar weighted...

See More

Top 10 Holdings

Name % Holdings
Agios Pharmaceuticals 10,000.00%
United Therapeutics Corp 10,000.00%
EXACT SCIENCES 10,000.00%
IQVIA HOLDINGS 10,000.00%
BIOTECHNE CORP 10,000.00%
BioMarin Pharmaceutical Inc 10,000.00%
ILLUMINA INC 10,000.00%
INCYTE CORP 10,000.00%
Ionis Pharmaceuticals 10,000.00%
Ultragenyx Pharmaceutical Inc 10,000.00%

See More

Key Turning Points

2nd Resistance Point 158.47
1st Resistance Point 156.90
Last Price 155.33
1st Support Level 153.82
2nd Support Level 152.31

See More

52-Week High 180.64
Last Price 155.33
Fibonacci 61.8% 152.92
Fibonacci 50% 144.36
Fibonacci 38.2% 135.80
52-Week Low 108.08

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar